For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220920:nRST8406Za&default-theme=true
RNS Number : 8406Z Braveheart Investment Group plc 20 September 2022
Prior to publication, the information contained within this announcement was
deemed by the Company to constitute inside information as stipulated under the
UK Market Abuse Regulation. With the publication of this announcement, this
information is now considered to be in the public domain.
20 September 2022
Braveheart Investment Group Plc
("Braveheart", the "Company" or the "Group")
Placing and subscription to raise £750,000
Braveheart Investment Group (AIM: BRH), announces that the Company has raised
£750,000 (before expenses) by way of a placing of and subscription for new
ordinary shares of 2p each ("Ordinary Shares") in the Company (together, the
"Fundraise"), at an issue price of 10.25p pence per share (the "Issue Price").
The Company has issued 1,951,220 new Ordinary Shares ("Placing Shares") at the
Issue Price pursuant to a placing, raising gross proceeds of £200,000.05
before expenses (the "Placing"). The Placing has been arranged by Peterhouse
Capital Limited.
In addition, the Company has entered into a direct subscription with Trevor
Brown, Chief Executive Officer, for a total of 5,365,853 new Ordinary Shares
(the "Subscription Shares"), raising a total of £550,000 (the
"Subscription"). Trevor Brown has undertaken to the Company that he will not
dispose of any of the Subscription Shares for a period of one year from the
date of admission to trading on the AIM market of the Subscription Shares,
without the prior written consent of the Company and the Company's Nomad.
A total of 7,317,073 new Ordinary Shares (together the "Fundraise Shares") are
to be issued at the Issue Price. The Fundraise has been conducted utilising
the Company's existing share authorities granted at the Annual General Meeting
of the Company held on 13 July 2022. The Fundraise is conditional, inter
alia, on admission of the Fundraise Shares to trading on AIM ("Admission")
becoming effective.
The Fundraise has been undertaken by the Company to enable it to be in
sufficient funds to be able to support its current investee companies from a
position of strength should the need arise for further funds and to be able to
make opportunistic new investments.
Director's holding
Trevor Brown's total beneficial interest following this transaction will be
12,429,424 Ordinary Shares, representing approximately 19.51% of the voting
rights in the Company's enlarged share capital following the issue of the
Subscription Shares. The FCA notification, made in accordance with the
requirements of the UK Market Abuse Regulation, is appended below.
Related Party Transaction
The subscriber for the Subscription Shares is Trevor Brown, who is the CEO and
a Director of Braveheart and, therefore, the transaction is treated as a
related party transaction under the AIM rules. The independent directors,
being Qu Li, Susan Hagan and Vivian Hallam, consider, having consulted with
Allenby Capital Limited, the Company's Nominated Adviser, that the terms of
the Subscription and the issue of the Subscription Shares are fair and
reasonable insofar as the shareholders of Braveheart are concerned.
Admission of the Fundraise Shares
Application has been made for the 7,317,073 Fundraise Shares to be admitted to
trading on AIM ("Admission"), which is expected to take place on or around 26
September 2022. Once issued, the Fundraise Shares will rank pari passu in all
respects with the existing Ordinary Shares of the Company.
Total Voting Rights
Following Admission, the Company's issued ordinary share capital will consist
of 63,723,489 Ordinary Shares, all of which carry one voting right per share.
The Company does not hold any Ordinary Shares in treasury. Therefore, the
total number of Ordinary Shares and voting rights in the Company will be
63,723,489. With effect from Admission, this figure may be used by
shareholders as the denominator for the calculations by which they will
determine if they are required to notify their interest in, or a change to
their interest in, the Company under the FCA's Disclosure Guidance and
Transparency Rules.
For further information:
Braveheart Investment Group plc Tel: 01738 587555
Trevor Brown, Chief Executive Officer
Viv Hallam, Executive Director
Allenby Capital Limited (Nominated Adviser and Joint Broker) Tel: 020 3328 5656
David Worlidge / James Reeve / George Payne
Peterhouse Capital Limited (Joint Broker) Tel: 020 7469 0936
Heena Karani / Lucy Williams
Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Trevor Brown
2 Reason for the notification
a) Position/status Chief Executive Officer
b) Initial notification /Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Braveheart Investment Group plc
b) LEI 2138006HQ3COMU626I61
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of 2 pence each in Braveheart Investment Group plc
Identification code
GB00B13XV322
b) Nature of the transactions issue of new Ordinary Shares
c) Price(s) and volume(s) Price(s) Volume(s)
10.25p 5,365,853
d) Aggregated information
- Aggregated volume 5,365,853
- Price 10.25p
- Principal amount £ 549,999.93
e) Dates of the transaction 16 September 2022
f) Place of transaction Outside a trading venue
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END IOESFLFEAEESEFU